| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 03/20/2007 | US7192766 Sensor containing molded solidified protein |
| 03/20/2007 | US7192762 nucleic acid fragment isolated from fungi, that code for transferase enzymes, used in the manufacture of oils enriched in omega fatty acids in microorganisms such as algae, bacteria, fungi or yeasts; genetic engineering |
| 03/20/2007 | US7192745 Amplification of target nucleic acid; obtain nucleotide sequences, incubate with primers, expose to reaction miture and polymerase, amplify, recover reaction product |
| 03/20/2007 | US7192741 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using such DNA sequences |
| 03/20/2007 | US7192739 Ligand-dependent protein splicing |
| 03/20/2007 | US7192735 Phosphopantetheinyl transferases and uses thereof |
| 03/20/2007 | US7192734 Method of testing for the presence of microorganisms in a gaseous environment comprising hydrogen peroxide |
| 03/20/2007 | US7192733 screening for drugs that inhibit prostaglandin endoperoxidase (PGE) synthase, for use in treatment of inflammation, arthritis, cancer, Alzheimer's disease, in modulating apoptosis, and treating pain |
| 03/20/2007 | US7192732 contacting proteins with test compounds, then analyzing binding between the protein and the test compound; screening for drugs which can be used to treat allergic disease, asthma, cancer and neurodegenerative diseases |
| 03/20/2007 | US7192731 Containing fatty ester; desterification using esterase |
| 03/20/2007 | US7192730 Comprises nucleotide sequences coding serine protease for use as tool in proteolysis, food processing and waste removal |
| 03/20/2007 | US7192729 Methods for assaying homocysteine |
| 03/20/2007 | US7192728 Screening assays for agents that alter inhibitor of apoptosis (IAP) protein regulation of caspase activity |
| 03/20/2007 | US7192727 comprising L-alanine, 2-oxoglutaric acid, lactate dehydrogenase, reduced nicotinamide adenine dinucleotide and lactate dehydrogenase inhibitors |
| 03/20/2007 | US7192726 Method of using platelet contractile force and whole blood clot elastic modulus as clinical markers |
| 03/20/2007 | US7192721 Universal rapid test and method for detection of tuberculosis in multiple host species |
| 03/20/2007 | US7192720 Array-based epitope-captured antibody display |
| 03/20/2007 | US7192717 GASP1: a follistatin domain containing protein |
| 03/20/2007 | US7192714 Detecting proteolysis of an low density lipoprotein receptor transmembrane domain; obtain sample containing receptor polypeptide, incubate with protease, detect and recover cleavage product |
| 03/20/2007 | US7192712 used as the internal standard in gene expression analysis |
| 03/20/2007 | US7192711 using tumor-associated genes and encoded gene products in tumor diagnosis |
| 03/20/2007 | US7192710 Using molecular beacon probe arrays for detection of preferential biopolymers in solution; analyzing DNA/RNA binding proteins and their domains; protein fingerprinting |
| 03/20/2007 | US7192709 Methods for identification, assessment, prevention, and therapy of cancer |
| 03/20/2007 | US7192708 Nucleic acid enzyme biosensors for ions |
| 03/20/2007 | US7192707 used in linkage analysis to track disease genes in human pedigrees or economically important traits in animal and plant breeding programmes; forensic and paternity testing; to discover mutations in biologically and clinically important genes |
| 03/20/2007 | US7192706 Growth regulating proteins |
| 03/20/2007 | US7192705 Nucleotide sequences coding transmembrane cochlear-expressed gene 1(TDC1) protein for use in diagnosis, prognosis and treatment of hearing loss |
| 03/20/2007 | US7192704 Methods for detection and treatment of neural cancers |
| 03/20/2007 | US7192703 Quantitation analysis; attaching one or more target biomolecules to a substrate; using primer to produce one or more rolling circle amplification (RCA) products; detecting each amplification product by Raman spectroscopy; identifying one or more target biomolecules by presence of amplification product |
| 03/20/2007 | US7192702 Modulators of the interaction between Arp2/3 and cortactin or HS-1 |
| 03/20/2007 | US7192701 Using chromatographic strip comprising immobilized nucleotide sequences to diagnose chlamydial infection |
| 03/20/2007 | US7192700 Methods and compositions for conducting primer extension and polymorphism detection reactions |
| 03/20/2007 | US7192698 EphA2 as a diagnostic target for metastatic cancer |
| 03/20/2007 | US7192697 Procedure for anti-Limulus-factors-independent determination of lipopolysaccharide- and/or lipid-A- and/or glucan- reactivity, suitable test system for this as well as its usage |
| 03/20/2007 | US7192589 Treatment of inflammatory disorders with STIgMA immunoadhesins |
| 03/20/2007 | US7192586 Topical administration of an anti-PSMA antibody alone or conjugated to a cytotoxic moiety to the extracellular domain of human prostate specific membrane antigen (PSMA); anti-proliferative agents and - carcinogenic agents |
| 03/20/2007 | US7192583 Transforming growth factor binding proteins; fusion proteins; knockout animal models; for treatment of osteoporosis/ fractures |
| 03/20/2007 | US7192582 Human monoclonal antibodies to FC alpha receptor (CD89) |
| 03/20/2007 | US7192580 Purging of cells using viruses |
| 03/20/2007 | US7192578 By administering antiinflammatory drugs |
| 03/20/2007 | US7192560 Methods and devices for removal of organic molecules from biological mixtures using anion exchange |
| 03/20/2007 | US7191670 Automatic microbial air sampling system and method |
| 03/20/2007 | CA2315218C Analysis of predisposition based on human airway tripsin protease gene polymorphism |
| 03/20/2007 | CA2308766C Diagnostic assay for cancer susceptibility |
| 03/20/2007 | CA2281898C Promiscuous g-protein compositions and their use |
| 03/20/2007 | CA2180954C Inhibitors of human plasmin derived from the kunitz domains |
| 03/20/2007 | CA2112675C Methods and apparatus for improved luminescence assays using particle concentration and chemiluminescence detection |
| 03/20/2007 | CA2040529C Farnesyl-protein transferase assay for identifying compounds that block neoplastic transformation |
| 03/20/2007 | CA2002868C Single domain ligands, receptors comprising said ligands, methods for their production, and use of said ligands and receptors |
| 03/16/2007 | CA2623597A1 Reaction sensing in living cells |
| 03/16/2007 | CA2560115A1 System and method for preparative mass spectrometry |
| 03/16/2007 | CA2559779A1 System and method for landing of ions on a gas/liquid interface |
| 03/15/2007 | WO2007030815A1 Methods for determining the pathogenicity of viral strains |
| 03/15/2007 | WO2007030806A2 Process of stripping a microarray for reuse |
| 03/15/2007 | WO2007030759A2 Improved nucleic acid amplification procedure |
| 03/15/2007 | WO2007030678A2 Methods of genome-wide location analysis in stem cells |
| 03/15/2007 | WO2007030611A2 A calculated index of genomic expression of estrogen receptor (er) and er related genes |
| 03/15/2007 | WO2007030505A1 Methods, compositions and kits for isothermal amplification of nucleic acids |
| 03/15/2007 | WO2007030473A2 Luciferases and methods for making and using the same |
| 03/15/2007 | WO2007030454A2 Mutations and polymorphisms of hdac9 |
| 03/15/2007 | WO2007030373A2 Method for in situ hybridization analysis |
| 03/15/2007 | WO2007030197A1 Modified venom and venom components as anti-retroviral agents |
| 03/15/2007 | WO2007030169A1 Method of evaluating and measuring the smell of urine in a material |
| 03/15/2007 | WO2007030019A1 A method of manufacture |
| 03/15/2007 | WO2007029857A1 Method for determination of infectiousness with hepatitis b virus |
| 03/15/2007 | WO2007029854A1 Inhibitor for lachrymatory factor synthase |
| 03/15/2007 | WO2007029821A1 Apparatus for counting the number of microorganisms |
| 03/15/2007 | WO2007029809A1 Method for test on latent viral infection and kit for use in the test |
| 03/15/2007 | WO2007029415A1 Protein constituting voltage-activated proton channel and use thereof |
| 03/15/2007 | WO2007029262A2 Compositions and methods using same for the detection of viruses |
| 03/15/2007 | WO2007029200A2 Ssb - polymerase fusion proteins |
| 03/15/2007 | WO2007029037A2 Class iia histone deacetylase (hdac) substrate |
| 03/15/2007 | WO2007029035A2 Thiophene and thiazole substituted trifluoroethanone derivatives as histone deacetylase (hdac) inhibitors |
| 03/15/2007 | WO2007029030A2 Method for identifying modulators of gamma secretase or notch |
| 03/15/2007 | WO2007028795A1 Nucleic acid variants in the masp-2 gene associated with altered innate immunity |
| 03/15/2007 | WO2007028649A1 Medium for detecting microorganisms |
| 03/15/2007 | WO2007028608A2 Nucleic acid-binding chips for detecting nitrogen deficiencies as part of bioprocess control |
| 03/15/2007 | WO2007028580A2 Single receptor assays for immunosuppressive drugs |
| 03/15/2007 | WO2007028414A1 Use of both rd9 and is6110 as nucleic acid targets for the diagnosis of tuberculosis, and provision of multiplex-compliant is6110 and rd9 targets |
| 03/15/2007 | WO2007028289A1 A microvalve controlled precision fluid dispensing apparatus with a self-purging feature and method for use |
| 03/15/2007 | WO2006131853A3 In vivo expression profiling |
| 03/15/2007 | WO2006131537A3 Methods for the diagnosis of immune graft tolerance |
| 03/15/2007 | WO2006119368A3 Fluorescent detection system and dye set for use therewith |
| 03/15/2007 | WO2006119066A3 Amplification and cloning of single dna molecules using rolling circle amplification |
| 03/15/2007 | WO2006117676A3 Method for the detection and characterization of microorganisms on a filter |
| 03/15/2007 | WO2006110449A3 Agglomeration protein cascades, compositions and methods regarding the same |
| 03/15/2007 | WO2006110350A3 Method of fabricating lipid bilayer membranes on solid supports |
| 03/15/2007 | WO2006106558A3 Use of nothobranchius furzeri as a model system for the characterisation of genes that control ageing |
| 03/15/2007 | WO2006104979A3 Method for detecting a target analyte |
| 03/15/2007 | WO2006104912A9 C-met mutations in lung cancer |
| 03/15/2007 | WO2006103111A3 Improved bisulfite conversion of dna |
| 03/15/2007 | WO2006102497A3 Methods and compositions for diagnosis, monitoring and development of therapeutics for treatment of atherosclerotic disease |
| 03/15/2007 | WO2006099451A3 Novel human, feline, chicken and other animal interferons and uses thereof |
| 03/15/2007 | WO2006097234A3 Microarray and method for genotyping shv beta lactamases |
| 03/15/2007 | WO2006094103A3 Methods for treating and diagnosing susceptibility to cytosolic pathogens |
| 03/15/2007 | WO2006085065A3 Vagal afferent neurons as targets for treatment |
| 03/15/2007 | WO2006071466A3 Methods and nucleic acids for the analysis of gene expression associated with the prognosis of prostate cell proliferative disorders |
| 03/15/2007 | WO2006056340A3 Method for determining genotoxicity |
| 03/15/2007 | WO2006038089A3 Method for identification of neoplastic transformation with particular reference to prostate cancer |
| 03/15/2007 | WO2006033928A3 Compositions, methods, and kits for identifying and quantitating small rna molecules |